Citations

Clear

5486 citation(s) found for "Yu, Stephen".

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
Morgan, Todd M. , Boorjian, Stephen A. , Buyyounouski, Mark K. , Chapin, Brian F. , Chen, David Y.T. , Jacene, Heather A. , Kim, Sennett K., Kirkby, Erin, Nathanson, B.J., Posadas, Edwin M. , Morgan, Todd M , Cheng, Heather H. , Chou, Roger , Kamran, Sophia C. , Luckenbaugh, Amy N. , Nathanson, Ben J., Nyame, Yaw A. , Tran, Phuoc T , Chen, Ronald C.

Mayo Clinic

Journal of Urology | February 29, 2024 | Volume: 211 | Issue: 4 | Pages: 518-525

10.1097/ju.0000000000003891 | PMID 38421243 Get It

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
Morgan, Todd M. , Boorjian, Stephen A. , Buyyounouski, Mark K. , Chapin, Brian F. , Chen, David Y.T. , Jacene, Heather A. , Kim, Sennett K., Kirkby, Erin, Nathanson, B.J., Posadas, Edwin M. , Morgan, Todd M , Cheng, Heather H. , Chou, Roger , Kamran, Sophia C. , Luckenbaugh, Amy N. , Nathanson, Ben J., Nyame, Yaw A. , Tran, Phuoc T , Chen, Ronald C.

Mayo Clinic

Journal of Urology | February 29, 2024 | Volume: 211 | Issue: 4 | Pages: 509-517

10.1097/ju.0000000000003892 | PMID 38421253 Get It

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
Morgan, Todd M. , Boorjian, Stephen A. , Buyyounouski, Mark K. , Chapin, Brian F. , Chen, David Y.T. , Jacene, Heather A. , Kim, Sennett K., Kirkby, Erin, Nathanson, B.J., Posadas, Edwin M. , Morgan, Todd M , Cheng, Heather H. , Chou, Roger , Kamran, Sophia C. , Luckenbaugh, Amy N. , Nathanson, Ben J., Nyame, Yaw A. , Tran, Phuoc T , Chen, Ronald C.

Mayo Clinic

Journal of Urology | February 29, 2024 | Volume: 211 | Issue: 4 | Pages: 526-532

10.1097/ju.0000000000003890 | PMID 38421252 Get It

Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs
Nguyen, Sierra, Oberg, Ann L. , Petersen, Gloria M. , Carmella, Steven G. , Jansen, Rick J. , Oberg, Ann L , Jansen, Rick J , Carlson, Heather, Yoder, Andrea R. , Bamlet, William R. , Hecht, Stephen S.

Mayo Clinic

Nutrients | February 29, 2024 | Volume: 16 | Issue: 5 | Pages: 688

10.3390/nu16050688 | PMID 38474816 Get It

Exposure to polycyclic aromatic hydrocarbons (PAHs), byproducts of incomplete combustion, and their effects on the development of cancer are still being evaluated. Recent studies have analyzed the relationship between PAHs and tobacco or dietary intake in the form of processed foods and smoked/well-done meats. This study aims to assess the association of a blood biomarker and metabolite of PAHs, r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT), dietary intake, selected metabolism SNPs, and pancreatic cancer. Demographics, food-frequency data, SNPs, treatment history, and levels of PheT in plasma were determined from 400 participants (202 cases and 198 controls) and evaluated based on pancreatic adenocarcinoma diagnosis. Demographic and dietary variables were selected based on previously published literature indicating association with pancreatic cancer. A multiple regression model combined the significant demographic and food items with SNPs. Final multivariate logistic regression significant factors (p-value < 0.05) associated with pancreatic cancer included: Type 2 Diabetes [OR = 6.26 (95% CI = 2.83, 14.46)], PheT [1.03 (1.02, 1.05)], very well-done red meat [0.90 (0.83, 0.96)], fruit/vegetable servings [1.35 (1.06, 1.73)], recessive (rs12203582) [4.11 (1.77, 9.91)], recessive (rs56679) [0.2 (0.06, 0.85)], overdominant (rs3784605) [3.14 (1.69, 6.01)], and overdominant (rs721430) [0.39 (0.19, 0.76)]. Of note, by design, the level of smoking did not differ between our cases and controls. This study does not provide strong evidence that PheT is a biomarker of pancreatic cancer susceptibility independent of dietary intake and select metabolism SNPs among a nonsmoking population.
Maternal and child life years gained by transfusing low titer group O whole blood in trauma: A computer simulation
Yazer, Mark H. , Leeper, Christine M. , Spinella, Philip C. , Emery, Stephen P. , Horvath, Sarah , Seheult, Jansen N. , Leeper, Christine , Spinella, Philip C , Seheult, Jansen N

Mayo Clinic

Transfusion | February 26, 2024 | Volume: 64 | Issue: S2 | Pages: No page available

10.1111/trf.17767 | PMID 38404198 Get It

AbstractBackgroundUsing low titer group O whole blood (LTOWB) is increasingly popular for resuscitating trauma patients. LTOWB is often RhD‐positive, which might cause D‐alloimmunization and hemolytic disease of the fetus and newborn (HDFN) if transfused to RhD‐negative females of childbearing potential (FCP). This simulation determined the number of life years gained by the FCP and her future children if she was resuscitated with LTOWB compared with conventional component therapy (CCT).MethodsThe model simulated 500,000 injured FCPs of each age between 0 and 49 years with LTOWB mortality relative reductions (MRRs) compared with components between 0.1% and 25%. For each surviving FCP, number of life years gained was calculated using her age at injury and average life expectancy for American women. The number of expected future pregnancies for FCPs that did not survive was also based on her age at injury; each future child was assigned the maximum lifespan unless they suffered perinatal mortality or serious neurological events from HDFN.ResultsThe LTOWB group with an MRR 25% compared with CCT had the largest total life years gained. The point of equivalence for RhD‐positive LTOWB compared to CCT, where life years lost due to severe HDFN was equivalent to life years gained due to FCP survival/future childbearing, occurred at an MRR of approximately 0.1%.ConclusionIn this model, RhD‐positive LTOWB resulted in substantial gains in maternal and child life years compared with CCT. A >0.1% relative mortality reduction from LTOWB offset the life years lost to HDFN mortality and severe neurological events.
Longitudinal analysis of sensory responsivity from infancy to school age in children at high and low familial likelihood for autism
Gunderson, Jaclyn , Symons, Frank J. , Kohli, Nidhi , Grzadzinski, Rebecca , Burrows, Casey, Dager, Stephen R. , Piven, Joseph , Network, IBIS, Burrows, Casey, Estes, Annette Mercer , Wolff, Jason J. , Network, IBIS

Mayo Clinic

JCPP Advances | February 22, 2024 | Volume: 4 | Issue: 2 | Pages: No page available

10.1002/jcv2.12227 Get It

AbstractBackgroundEmpirical evidence regarding the development of sensory responsivity in young children at high likelihood to develop autism spectrum disorder (ASD) remains relatively limited. It is unclear how sensory responsivity behaviors may change over time and impact later developmental outcomes. The goals of this study were to (a) characterize developmental trajectories of sensory responsivity across infancy (∼12 months), toddlerhood (∼24 months), and school age (6–11 years) in children at high and low familial likelihood for ASD; and (b) determine if sensory responsivity in infancy predicts adaptive and cognitive functioning at school age among children with ASD.MethodsGeneralized linear mixed effects models were used to examine scores from the Sensory Experiences Questionnaire in three groups of children including high‐likelihood children later diagnosed with ASD (HL‐ASD; n = 30), high‐likelihood children without ASD (HL‐Neg; n = 150), and low‐likelihood control children not meeting ASD diagnostic criteria (LL‐Neg; n = 94). Hierarchical linear regression was then used to examine the association between sensory responsivity scores in infancy and functional adaptive and cognitive outcomes at school age for children at high likelihood of ASD.ResultsDevelopment of sensory responsivity from infancy to later childhood is best estimated by the effects of chronological age and Group for Sensory Seeking and Hypo responsivity and the additional effect of the interaction of Group and chronological age for Total and Hyper responsivity. Early elevated Hypo responsivity and Sensory Seeking scores are negatively associated with later adaptive behavior but not cognitive level.ConclusionOverall, higher degrees of Sensory Seeking and Hypo sensory responsivity are detectable in autistic children's behavioral repertoires by 12 months of age and associate with reduced adaptive functioning in middle childhood. These results point to the potential importance of early detection and treatment implications of early sensory behaviors.
Optimizing Neurovascular-Protective Transposition of the Pterygopalatine Fossa Through Orbito-Pterygo-Sphenoidal Ligament Release and Descending Palatine Canal Decompression: Anatomical Principles and Surgical Strategies
Leonel, Luciano, Mondesir, Ronsard, Graepel, Stephen , Peris‐Celda, Maria , Agosti, Edoardo , Pinheiro‐Neto, Carlos

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1779873 Get It

The prevalence of impostor phenomenon and its association with burnout amongst urologists
Jefferson, Francis A. , Fadel, Anthony , Robinson, Maraika , Seyer, A, Koo, Kevin , Granberg, Candace F. , Boorjian, Stephen A. , Anderson, Katherine T. , Robinson, Maraika O, Seyer, Amanda K., Koo, Kevin , Fadel, Anthony , Findlay, Bridget L.

Mayo Clinic

BJU International | February 20, 2024 | Volume: 133 | Issue: 5 | Pages: 579-586

10.1111/bju.16301 | PMID 38378021 Get It

Objectives To characterise the prevalence of impostor phenomenon (IP; tendency for high‐achieving individuals to perceive themselves as fraudulent in their successes) amongst attending staff in urology, to identify variables that predict more severe impostorism, and to study the association of IP with burnout. Subjects and Methods A survey composed of the Clance Impostor Phenomenon Scale (CIPS), demographic information, practice details, and burnout levels was e‐mailed to urologists via urological subspecialty societies. Survey results were analysed to identify associations between IP severity, survey respondent characteristics, and symptoms of professional burnout. This study was conducted in the United States of America. Results A total of 614 survey responses were received (response rate 11.0%). In all, 40% ( n = 213) of responders reported CIPS scores qualifying as either ‘frequent’ or ‘intense’ impostorism (i.e., scores of 61–100). On multivariable analysis, female gender, fewer years in practice (i.e., 0–2 years), and lower academic rank were all independently associated with higher CIPS scores (adjusted P < 0.05). Regarding burnout, 46% of responders reported burnout symptoms. On multivariable analysis, increase in CIPS score was independently associated with higher odds of burnout (odds ratio 1.06, 95% confidence interval 1.04–1.07; P < 0.001). Conclusion Impostor phenomenon is prevalent in the urological community and is experienced more severely in younger and female urologists. IP is also independently associated with burnout. Increased female representation may improve IP amongst our female colleagues. More work is needed to determine strategies that are effective in mitigating feelings of IP and professional burnout amongst urologists, particularly those earlier in their careers.
How a Fish Can “See” with its Skin
Carmichael, Stephen W.

Mayo Clinic

Microscopy Today | February 9, 2024 | Volume: 32 | Issue: 1 | Pages: 8-9

10.1093/mictod/qaad101 Get It

Validated Symptom Outcomes Following Septal Perforation Repair: Application of the NOSE‐Perf Scale
Taylor, Cullen M. , Bansberg, Stephen F. , Marino, Michael J. , Taylor, Cullen

Mayo Clinic

The Laryngoscope | February 9, 2024 | Volume: 134 | Issue: 7 | Pages: 3067-3072

10.1002/lary.31329 | PMID 38334159 Get It

ObjectiveThe Nasal Obstruction Symptom Evaluation (NOSE)‐Perf scale was developed and validated to measure symptoms associated with nasal septal perforations. This study reports the application of the NOSE‐Perf scale to evaluate symptom change following septal perforation repair.MethodsPatients with NOSE‐Perf evaluations ≥6 months following attempted perforation closure from July 2018 to December 2021 utilizing bilateral nasal mucosal flaps with an interposition graft were eligible for study inclusion. Change in NOSE‐Perf scores were noted. Patient demographics, perforation size, and concurrent functional procedures were analyzed for impact on symptom outcomes.ResultsOne‐hundred and seventeen patients met the study criteria. Seventy‐nine (67.5%) of the patients were female and the mean (range) age at surgery was 47.3 (14–78) years. Repair failure was noted in 7 (6.0%) patients. Mean (SD) preoperative NOSE‐Perf score was 25.3 (95% CI, 23.5–27.1) and postoperative score was 7.9 (95% CI, 6.5–9.3). Minimal clinically important difference (MCID) was estimated and greater than 91% of patients had improvement above this threshold. Patient age, perforation size, or concurrent functional procedures did not impact outcomes. Postoperative scores at short (2–4 months), intermediate (5–8 months), and long‐term (≥9 months) time periods showed significant improvement (all p < 0.001) compared to preoperative NOSE‐Perf scores.ConclusionSignificant reduction in nasal symptoms as measured by the NOSE‐Perf scale is noted following bilateral mucosal flap repair. Although the nose does not completely normalize following repair, clinically important improvement was noted in at least 91% of patients. The NOSE‐Perf scale is positioned to play a role in the standardization of septal perforation evaluation and outcomes assessment.Level of Evidence4 Laryngoscope, 134:3067–3072, 2024